Nitroglycerin transdermal - Nometics

Drug Profile

Nitroglycerin transdermal - Nometics

Alternative Names: Glyceryl trinitrate - Nometics; GTN - Nometics; NOVade

Latest Information Update: 29 Jan 2016

Price : $50

At a glance

  • Originator Nometics; Queens University
  • Developer Queens University
  • Class Erectile dysfunction therapies; Heart failure therapies; Ischaemic heart disorder therapies; Nitro compounds; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Prostate cancer
  • Preclinical Colorectal cancer; Non-small cell lung cancer

Most Recent Events

  • 16 Jul 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top